Back to search

26 ORAL Phase Ib and pharmacodynamic study of the MEK inhibitor AZD6244 (ARRY-142886) in patients with advanced solid malignancies

Alex A. Adjei, Robert Cohen, Wilbur A. Franklin, Jesús Tornero Molina, Sreedharan Hariharan
DOI: 10.1016/s1359-6349(06)70031-3
European Journal of Cancer Supplements

Data up to Jan 2025

Published2006
Citations7
References0
Fields
Computer scienceEngineeringMathematicsPhysicsMathematical optimizationAutomotive engineeringElectrical engineering

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
26 ORAL Phase Ib and pharmacodynamic study of the MEK inhibitor AZD6244 (ARRY-142886) in… (2006) – European Journal of Cancer Supplements | Metascience Observatory Explorer